| Financial Year |
March 31 2023 |
| Monetary Funds |
155,248,431.57 |
| Held-for-trading Financial Assets |
40,000,000.00 |
| Notes Receivable |
21,763,746.28 |
| Accounts Receivable |
143,218,724.03 |
| Advances to Suppliers |
32,230,560.56 |
| Other Receivables |
1,528,196.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
143,806,067.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
430,377.51 |
| Total Current Assets |
629,780,177.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,804,139.43 |
| Investment Properties |
-- |
| Fixed Assetes |
715,653,138.18 |
| Under-construction Projects |
29,322,915.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
56,878,023.00 |
| R&D expenses |
-- |
| Goodwill |
21,467,008.68 |
| Long-Term Deferred and Prepaid Expenses |
7,325,662.55 |
| Deferred Income Tax Assets |
12,999,142.49 |
| Other Non-Current Assets |
30,611,172.95 |
| Sub-Total of Non-Current Assets |
882,574,357.53 |
| Total Assets |
1,512,354,535.15 |
| Short-Term Loans |
32,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
55,004,410.23 |
| Accounts Payable |
29,395,006.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,295,379.45 |
| Taxes Payable |
11,959,764.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
378,809.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
875,820.56 |
| Sub-Total of Current Liabilities |
143,800,472.78 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,843,914.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
75,675,756.44 |
| Total Liabilities |
219,476,229.22 |
| Paid-In Capital(Or Share Stock) |
165,679,281.00 |
| Capital Surplus |
232,640,327.65 |
| Surplus Reserve |
86,155,285.94 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
820,884,526.40 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,292,878,305.93 |
| Owner's Equity（Stockholder's Equity） |
1,292,878,305.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,512,354,535.15 |
